Skip to content

A Comparative Study on Clinical Outcomes and Quality of Life in Patients with Chronic Spontaneous Urticaria between Telemedicine and In-person Visits

Assessment of clinical aspect and quality of life in chronic spontaneous urticaria patients between telemedicine services and in-person visits

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20251006002
Enrollment
50
Registered
2025-10-06
Start date
2024-09-09
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Spontaneous Urticaria (CSU), an inflammatory skin disorder characterized by recurrent wheals, angioedema, or both, lasting for more than 6 weeks without an identifiable external trigger. telemedicine, chronic spontaneous urticaria, quality of life, patient satisfaction

Interventions

Patients with chronic spontaneous urticaria who receive follow-up through telemedicine consultations. Disease activity, quality of life, and satisfaction are assessed remotely over a 6-month period.,P
Treatment,Treatment
Telemedicine ,In-person

Sponsors

None
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with chronic spontaneous urticaria (CSU), history of recurrent wheals, angioedema, or both for more than 6 weeks without identifiable external triggers 2.Patients willing and able to participate in follow-up visits through either telemedicine or in-person consultations as assigned 3. Patients who have provided written informed consent

Exclusion criteria

Exclusion criteria: 1.Patients with other forms of chronic urticaria such as inducible urticaria (e.g., cold-induced, cholinergic, dermographism) 2.Patients unwilling or unable to comply with study procedures 3.Patients who did not provide written informed consent

Design outcomes

Primary

MeasureTime frame
Disease activity assessed at baseline, 3 months, and 6 months after enrollment Urticaria Activity Score over 7 days,Quality of life assessed at baseline, 3 months, and 6 months after enrollment Thai Chronic Urticaria Quality of Life Questionnaire

Secondary

MeasureTime frame
Patient satisfaction with telemedicine services assessed at 6 months after enrollment Telehealth Usability Questionnaire

Countries

Thailand

Contacts

Public ContactPajaree Khemachit

Phramongkutklao hospital

pajareekhe@gmail.com035514999

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026